The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 20, 2023

Filed:

Nov. 12, 2019
Applicant:

Astellas Pharma Inc., Chuo-ku, JP;

Inventors:

Akifumi Morinaka, Tokyo, JP;

Hiroki Shirai, Tokyo, JP;

Kazunori Hirayama, Tokyo, JP;

Naomi Hosogai, Tokyo, JP;

Hitoshi Doihara, Tokyo, JP;

Assignee:

Astellas Pharma Inc., Chuo-ku, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C07K 16/30 (2006.01); A61K 47/54 (2017.01); A61K 51/10 (2006.01); C12N 15/85 (2006.01); G01N 33/574 (2006.01); C07K 16/18 (2006.01); A61K 49/16 (2006.01); C12N 5/10 (2006.01); A61K 39/395 (2006.01); C07K 17/00 (2006.01); C12P 21/02 (2006.01); C12N 15/09 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0058 (2013.01); A61K 39/395 (2013.01); A61K 47/54 (2017.08); A61K 47/6851 (2017.08); A61K 47/6855 (2017.08); A61K 49/0032 (2013.01); A61K 49/0036 (2013.01); A61K 49/16 (2013.01); A61K 51/1093 (2013.01); A61P 35/00 (2018.01); C07K 16/18 (2013.01); C07K 16/30 (2013.01); C07K 16/3092 (2013.01); C07K 17/00 (2013.01); C12N 5/10 (2013.01); C12N 15/09 (2013.01); C12N 15/85 (2013.01); C12P 21/02 (2013.01); G01N 33/57407 (2013.01); G01N 33/57415 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/40 (2013.01); C07K 2317/55 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/4725 (2013.01);
Abstract

The problem to be solved is to provide an anti-human MUC1 antibody Fab fragment that is expected to be useful in the diagnosis and/or treatment of a cancer, particularly, the diagnosis and/or treatment of breast cancer or bladder cancer, and a diagnosis approach and/or a treatment approach using a conjugate comprising the Fab fragment. The solution is an anti-human MUC1 antibody Fab fragment comprising a heavy chain fragment comprising a heavy chain variable region consisting of the amino acid sequence represented by SEQ ID NO: 8 or 10, and a light chain comprising a light chain variable region consisting of the amino acid sequence represented by SEQ ID NO: 12, and a conjugate comprising the Fab fragment.


Find Patent Forward Citations

Loading…